Description:Ro-31-7549, with the CAS number 125313-65-7, is a selective and potent inhibitor of protein kinase C (PKC). This compound is primarily studied for its potential therapeutic applications, particularly in the context of cancer and cardiovascular diseases, where PKC plays a significant role in cell signaling and proliferation. Ro-31-7549 exhibits a high degree of specificity for certain PKC isoforms, making it a valuable tool in biochemical research for understanding the pathways regulated by PKC. The compound is typically characterized by its ability to modulate various cellular processes, including apoptosis and differentiation, by interfering with PKC-mediated signaling pathways. Its pharmacological profile suggests that it may have implications in the development of novel treatments targeting diseases associated with dysregulated PKC activity. However, as with many research compounds, further studies are necessary to fully elucidate its mechanisms of action and potential side effects in clinical settings.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.